UnitedHealth Group Shares Rise After Analyst Upgrade

Shares of the healthcare giant jump 1.2% on positive analyst commentary.

Apr. 2, 2026 at 8:55pm

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, interlocking metal gears and levers, conveying the complex, industrial nature of the financial sector.The upgrade of UnitedHealth Group's stock signals continued strength in the healthcare industry's institutional infrastructure.Minnetonka Today

Shares of UnitedHealth Group (NYSE: UNH) rose 1.2% on Thursday after Raymond James Financial upgraded the stock from 'market perform' to 'outperform' and set a $330 price target. The healthcare conglomerate's stock traded as high as $279.04 on the day, though it closed at $277.30.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the U.S., providing insurance, pharmacy benefits, and other services. Positive analyst sentiment can move the stock price and impact investor sentiment around the company's future prospects.

The details

Raymond James Financial cited the company's strong market position and growth potential as reasons for the upgrade. UnitedHealth Group has faced some headwinds recently, with its stock price declining from highs near $415 last year. However, the company remains a dominant player in the healthcare industry.

  • UnitedHealth Group shares traded as high as $279.04 on Thursday, April 2, 2026.

The players

UnitedHealth Group

A diversified healthcare company that provides insurance, pharmacy benefits, and other services. It is one of the largest healthcare companies in the United States.

Raymond James Financial

A financial services firm that provides investment banking, asset management, and other financial services. It upgraded UnitedHealth Group's stock to 'outperform' and set a $330 price target.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

What’s next

Investors will be closely watching UnitedHealth Group's upcoming earnings report and any further analyst commentary on the stock.

The takeaway

The positive analyst upgrade highlights the ongoing strength and resilience of UnitedHealth Group, one of the healthcare industry's most dominant players. However, the company continues to face some headwinds, underscoring the need for vigilance in the rapidly evolving healthcare landscape.